Outcome of AGM
Venus Remedies Ltd has informed BSE that the Annual General Meeting (AGM) of the Company was held on September 28, 2012. (For more details kindly refer Corporate Announcements on www.bseindia.com).28-09-2012
28-09-2012
Venus wins Manufacturing Leadership Award 2012
Venus Remedies Ltd has informed BSE that the Company has won Manufacturing Award for its world class manufacturing and operational excellence at the "Industry 2.0 Manufacturing Innovation Conclave 2012". (For more details kindly refer Corporate Announcements on www.bseindia.com).18-09-2012
Venus Remedies Bags First Patent From Canada For Vancoplus
Venus Remedies Ltd has informed BSE regarding "Venus Remedies Bags First Patent From Canada For Vancoplus". (For more details kindly refer Corporate Announcements on www.bseindia.com).10-09-2012
Revised Press Release - Venus launches TROIS, a miracle nano-emulsion for arthritic Pain
With reference to earlier Press Release dated August 22, 2012 titled "Venus launches TRIOS, a miracle nano-emulsion for arthritic Pain". Venus Remedies Ltd has now informed BSE a Revised Press Release "Venus launches TROIS, a miracle nano-emulsion for arthritic Pain".23-08-2012
Venus launches TRIOS, a miracle nano-emulsion for arthritic Pain
Venus Remedies Ltd has informed BSE regarding "Venus launches TRIOS, a miracle nano-emulsion for arthritic Pain" (For more details kindly refer Corporate Announcements on www.bseindia.com).22-08-2012
Financial Results & Limited Review for June 30, 2012
Venus Remedies Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended June 30, 2012.04-08-2012
US patent protection for Venus' POTENTOX
Venus Remedies Ltd has informed BSE regarding "US patent protection for Venus' POTENTOX". (For more details kindly refer Corporate Announcements on www.bseindia.com).26-07-2012
Venus Remedies introduces "Ready-to-Use" Single Vial Taxedol in India
Venus Remedies Ltd has informed BSE regarding "Venus Remedies introduces "Ready-to-Use" Single Vial Taxedol in India".Announcement:"Venus Remedies Limited as introduced for the first time a nanotechnology bases " Ready-to-Use" Single Vial Docetaxel in the domestic market under the brand name "TAXEDOL". (For more details kindly refer Corporate Announcements on www.bseindia.com).09-07-2012
Fixes Book Closure for Dividend & AGM
Venus Remedies Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 24, 2012 to September 28, 2012 (both days inclusive) for the purpose of Payment of Dividend & Annual General Meeting (AGM) of the Company to be held on September 28, 2012.21-06-2012
Audited Financial Results for March 31, 2012
Venus Remedies Ltd has informed BSE about the Audited Financial Results for the period ended March 31, 2012.21-06-2012